Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Shan

Showing results (561-570 of 567) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 567 results.
The Journal of Allergy and Clinical Immunology|May 15, 2020
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in ChinaRuchong Chen, Ling Sang, Mei Jiang, et al.
National Science Review|October 22, 2021
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19Mingxing Huang, Man Li, Fei Xiao, et al.
Chest|April 19, 2020
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in ChinaRuchong Chen, Wenhua Liang, Mei Jiang, et al.
Cellular & Molecular Immunology|January 23, 2021
Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patientsYang Li, Dan-Yun Lai, Qing Lei, et al.
The New England Journal of Medicine|February 29, 2020
Clinical Characteristics of Coronavirus Disease 2019 in ChinaWei-Jie Guan, Zheng-Yi Ni, Yu Hu, et al.
The European Respiratory Journal|March 29, 2020
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysisWei-Jie Guan, Wen-Hua Liang, Yi Zhao, et al.
The European Respiratory Journal|April 10, 2020
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of ChinaWen-Hua Liang, Wei-Jie Guan, Cai-Chen Li, et al.
Pageof 57

Showing results (561-570 of 567) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 567 results.
The Journal of Allergy and Clinical Immunology|May 15, 2020
Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in ChinaRuchong Chen, Ling Sang, Mei Jiang, et al.
National Science Review|October 22, 2021
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19Mingxing Huang, Man Li, Fei Xiao, et al.
Chest|April 19, 2020
Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in ChinaRuchong Chen, Wenhua Liang, Mei Jiang, et al.
Cellular & Molecular Immunology|January 23, 2021
Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patientsYang Li, Dan-Yun Lai, Qing Lei, et al.
The New England Journal of Medicine|February 29, 2020
Clinical Characteristics of Coronavirus Disease 2019 in ChinaWei-Jie Guan, Zheng-Yi Ni, Yu Hu, et al.
The European Respiratory Journal|March 29, 2020
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysisWei-Jie Guan, Wen-Hua Liang, Yi Zhao, et al.
The European Respiratory Journal|April 10, 2020
Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of ChinaWen-Hua Liang, Wei-Jie Guan, Cai-Chen Li, et al.
Pageof 57